BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23959472)

  • 1. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
    Wang P; Sun L; Yu L; Wang H
    Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
    Chen D; Zhang YJ; Zhu KW; Wang WC
    Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
    Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
    Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
    Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
    Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
    Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
    J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
    Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
    Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
    Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Liu F; Zhang Q
    Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
    Ren W; Gu G
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
    Qu JT; Wang M; He HL; Tang Y; Ye XJ
    J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
    Zhuang Y; Wei M
    Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.